{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:34:10Z","timestamp":1772638450745,"version":"3.50.1"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.2169\/internalmedicine.0585-17","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T22:23:40Z","timestamp":1522362220000},"page":"2511-2515","source":"Crossref","is-referenced-by-count":4,"title":["A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis"],"prefix":"10.2169","volume":"57","author":[{"given":"Toru","family":"Kuwano","sequence":"first","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Fujiyama","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Liver Research Laboratory, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuji","family":"Arase","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","volume":"59","author":"H Kumada","year":"2014","unstructured":"1. Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 59: 2083-2091, 2014.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Askanas V, Engel WK. Sporadic inclusion body myositis and hereditary unclusion body myopathies. Arch Neurol 55: 915-920, 1998.","DOI":"10.1001\/archneur.55.7.915"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dalakas MC. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology 66: S33-S38, 2006.","DOI":"10.1212\/01.wnl.0000192129.65677.87"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Rosenthal E, Cacoub P. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus 24: 469-482, 2015.","DOI":"10.1177\/0961203314556140"},{"key":"5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000004333","volume":"89","author":"C Ikenaga","year":"2017","unstructured":"5. Ikenaga C, Kubota A, Kadoya M, et al. Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology. Neurology 89: 1-9, 2017.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"6","unstructured":"6. Tsuruta Y, Yamada T, Yoshimura T, et al. Inclusion body myositis associated with hepatitis C virus infection. Fukuoka Igaku Zasshi 92: 370-376, 2001 (in Japanese, Abstract in English)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Uruha A, Noguchi S, Hayashi YK, et al. Hepatitis C virus infection in inclusion body myositis: a case-control study. Neurology 86: 211-217, 2016.","DOI":"10.1212\/WNL.0000000000002291"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kase S, Shiota G, Fujii Y, et al. Inclusion body myositis associated with hepatitis C virus infection. Liver 21: 357-360, 2001.","DOI":"10.1034\/j.1600-0676.2001.210509.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Keller CW, Schmidt J, Lunemann JD, et al. Immune and myodegenerative pathomechanisms in inclusion body myositis. Ann Clin Transl Neurol 4: 422-445, 2017.","DOI":"10.1002\/acn3.419"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Varela-Rosario N, P\u00e9rez-Berenguer JL, Vila LM, et al. Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis. BMJ Case Rep 2016 (Epub ahead of print).","DOI":"10.1136\/bcr-2016-215035"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fabrizio F, Dixit V. Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies. J Med Virol 85: 1019-1027, 2013.","DOI":"10.1002\/jmv.23562"},{"key":"12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"12. Sise ME, Bloom AK, Wiscoky J, et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology 63: 408-417, 2016.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Makara M, Sulyok M, Csacsovszki O, Sulyok Z, V\u00e1lyi-Nagy I. Successful treatment of HCV-associated cryoglobulinemia with ombitasvir\/paritaprevir\/ritonavir, dasabuvir and ribavirin: A case report. J Clin Virol 72: 66-68, 2015.","DOI":"10.1016\/j.jcv.2015.09.003"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/17\/57_0585-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T18:14:07Z","timestamp":1570990447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/17\/57_0585-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":13,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0585-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}